Search
Kura Oncology Inc
KURAAdd to Watchlist
11.730USD
+0.010+0.09%
Close 09-18 16:00（ET）
1.04BMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
+0.09%
5 Days
+2.99%
1 Month
-6.38%
6 Months
+39.15%
Year to Date
+12.90%
1 Year
+42.18%
Key Figures
11.640Open
11.840High
136.43KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.15%Turnover Ratio
11.720Prev. Close
11.560Low
1.60MTurnover
LossP/E Static
21.54P/B
0.00%Div Yield TTM
-42.19%ROA
13.90052wk High
29.40Volume Ratio
-173.98MNet Profit
88.95MShares
-3.3490EPS TTM
0.34Beta
-124.74%ROE
7.35852wk Low
2.13%Amplitude
98.71%Gross Margin
1.04BMarket Cap
0.47Reward/Risk
3.77%Risk Rate
Kura Oncology Inc's Score
0.13vs previous score
Forecast8.25
Financial Health6.87
Technical5.15
Valuation Dimensions6.94
Institutional Confidence10.00
Risk Assessment5.59
Media Coverage
Coverage Level
Very Low
Very High
No data
Analyst Rating
Kura Oncology Inc Technical Analysis
Technical Indicators
Neutral
Summary
Neutral
Moving Average
Buy
Kura Oncology Inc Latest Earnings Call Transcripts
Kura Oncology (KURA) Q2 2026 Earnings Call: KOMZIFTI Sales Reach $9.1M
Kura Oncology’s Q2 2026 earnings call covered $9.1 million in KOMZIFTI sales, 115 new patient starts, pipeline updates and funding into 2028.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.77/-0.88
Revenue / Forecast
20.87M/21.42M
Kura Oncology Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolKURA
Number of employees192
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| BVF Partners L.P. | 9.71% |
| Suvretta Capital Management, LLC | 9.66% |
| BlackRock Institutional Trust Company, N.A. | 7.93% |
| Armistice Capital LLC | 5.56% |
| Shareholder Types | Proportion |
|---|---|
| Hedge Fund | 37.46% |
| Investment Advisor | 28.87% |
| Investment Advisor/Hedge Fund | 24.85% |
| Research Firm | 4.92% |
Related Instruments
+0.04%
-0.09%
-0.04%
-0.02%
-0.19%
-0.39%
+1.55%
-0.52%
+0.07%
+0.12%
+0.35%
-1.55%
-1.65%
-1.53%
-0.56%
-0.58%
-0.55%
-2.55%
-0.73%
-0.42%Popular Instruments
51734.000
-26.000 (-0.05%)
29664.700
+252.000 (+0.86%)
7659.100
+27.000 (+0.35%)
14420.000
+119.000 (+0.83%)
65079.000
+130.000 (+0.20%)
6230.800
-76.400 (-1.21%)
96.001
-1.985 (-2.03%)
336.130
-0.870 (-0.26%)
222.270
+2.930 (+1.34%)
4377.330
+36.350 (+0.84%)
FAQs
What is the current price of Kura Oncology Inc (KURA)?
The current price of Kura Oncology Inc (KURA) is 11.73.
What is the symbol of Kura Oncology Inc?
The ticker symbol of Kura Oncology Inc is KURA.
What is the 52-week high of Kura Oncology Inc?
The 52-week high of Kura Oncology Inc is 13.90.
What is the 52-week low of Kura Oncology Inc?
The 52-week low of Kura Oncology Inc is 7.36.
What is the market capitalization of Kura Oncology Inc?
The market capitalization of Kura Oncology Inc is 1.04B.
Is Kura Oncology Inc (KURA) currently rated as Buy, Hold, or Sell?
According to analysts, Kura Oncology Inc (KURA) has an overall rating of Buy, with a price target of 32.00.
What is the Earnings Per Share (EPS TTM) of Kura Oncology Inc (KURA)?
The Earnings Per Share (EPS TTM) of Kura Oncology Inc (KURA) is -3.35.